16-2084577-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_000548.5(TSC2):c.4355C>T(p.Ser1452Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000187 in 1,607,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S1452S) has been classified as Benign.
Frequency
Consequence
NM_000548.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152258Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000375 AC: 9AN: 239734Hom.: 0 AF XY: 0.0000228 AC XY: 3AN XY: 131684
GnomAD4 exome AF: 0.0000179 AC: 26AN: 1454626Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 723942
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152376Hom.: 0 Cov.: 34 AF XY: 0.0000268 AC XY: 2AN XY: 74512
ClinVar
Submissions by phenotype
Tuberous sclerosis 2 Uncertain:1Benign:1
- -
- -
not provided Uncertain:1
p.Ser1452Leu (TCG>TTG): c.4355 C>T in exon 34 of the TSC2 gene (NM_000548.3) The S1452L variant was previously reported as S1453L and was considered a benign polymorphism, although no additional information was provided (Au et al., 2007). According to the TSC2 LOVD Variant Database, it was identified in a patient with clinical features of tuberous sclerosis but was also identified in an unaffected parent. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The S1452L variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. However, this substitution does not occur within known functional domains of the tuberin protein, where many pathogenic missense mutations have been identified (Northrup et al., 2011; Au et al., 2007). In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. The variant is found in EPILEPSY panel(s). -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Tuberous sclerosis syndrome Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at